Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) Operating Income (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Operating Income data on record, last reported at $45.9 million in Q4 2025.

  • For Q4 2025, Operating Income rose 415.84% year-over-year to $45.9 million; the TTM value through Dec 2025 reached $16.9 million, up 125.57%, while the annual FY2025 figure was $16.9 million, 125.57% up from the prior year.
  • Operating Income reached $45.9 million in Q4 2025 per QTTB's latest filing, up from -$7.6 million in the prior quarter.
  • Across five years, Operating Income topped out at $45.9 million in Q4 2025 and bottomed at -$37.6 million in Q1 2022.
  • Average Operating Income over 5 years is -$16.3 million, with a median of -$16.4 million recorded in 2024.
  • Peak YoY movement for Operating Income: crashed 3285.96% in 2022, then skyrocketed 415.84% in 2025.
  • A 5-year view of Operating Income shows it stood at -$33.6 million in 2021, then decreased by 2.58% to -$34.5 million in 2022, then grew by 25.18% to -$25.8 million in 2023, then surged by 43.72% to -$14.5 million in 2024, then surged by 415.84% to $45.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Income were $45.9 million in Q4 2025, -$7.6 million in Q3 2025, and -$9.2 million in Q2 2025.